Cargando…

Effect of Vitamin K Epoxide Reductase Complex 1 Polymorphism on Warfarin Dose Requirement among Patients in Tertiary Care Hospital

BACKGROUND: Warfarin, anticoagulant is used for thromboembolic disorders. Inter-individual variation in clinical response to warfarin is due to various factors, including polymorphism of Vitamin K epoxide reductase complex 1 (VKORC1)-1639G>A. The aim of our study was to evaluate the effect of VKO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veeregowda, Sahana Hadihalli, Krishnaswamy, Bhuvana, Balakrishna, Sharath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289213/ https://www.ncbi.nlm.nih.gov/pubmed/32566525 http://dx.doi.org/10.4103/ijabmr.IJABMR_341_18

Ejemplares similares

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Structure of a bacterial homolog of vitamin K epoxide reductase
por: Li, Weikai, et al.
Publicado: (2010)

Vitamin K epoxide reductase regulation of androgen receptor activity
por: Tew, Ben Yi, et al.
Publicado: (2017)

Human Vitamin K Epoxide Reductase as a Target of Its Redox Protein
por: Ledoux, Julie, et al.
Publicado: (2022)

Vitamin K epoxide reductase and its paralogous enzyme have different structures and functions
por: Sinhadri, Balaji Chandra Sekhar, et al.
Publicado: (2017)

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
por: Shahabi, Payman, et al.
Publicado: (2018)

Structures of an intramembrane vitamin K epoxide reductase homolog reveal control mechanisms for electron transfer
por: Liu, Shixuan, et al.
Publicado: (2014)

Vitamin K epoxide reductase contributes to protein disulfide formation and redox homeostasis within the endoplasmic reticulum
por: Rutkevich, Lori A., et al.
Publicado: (2012)

Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphism as determinant of differences in Covid-19-related disease severity
por: Janssen, Rob, et al.
Publicado: (2020)

Vitamin K epoxide reductase complex subunit 1 (Vkorc1) haplotype diversity in mouse priority strains
por: Song, Ying, et al.
Publicado: (2008)

Genetic variation and haplotype structure of the gene Vitamin K epoxide reductase complex, subunit 1 in the Tamilian population
por: Kumar, Dhakchinamoorthi Krishna, et al.
Publicado: (2013)

Is there any association between osteoporotic vertebral fracture and vitamin K epoxide reductase complex subunit-1 polymorphism in Turkish society? A pilot study
por: Ozgen, Merih, et al.
Publicado: (2019)

New Insights on Vitamin K Metabolism in Senegalese sole (Solea senegalensis) Based on Ontogenetic and Tissue-Specific Vitamin K Epoxide Reductase Molecular Data
por: Beato, Silvia, et al.
Publicado: (2020)

Inter and intra ethnic variation of vitamin K epoxide reductase complex and cytochrome P450 4F2 genetic polymorphisms and their prevalence in South Indian population
por: Kumar, Dhakchinamoorthi Krishna, et al.
Publicado: (2013)

Comparison of two reducing agents dithiothreitol and tris(3-hydroxypropyl)phosphine for in vitro kinetic assay of vitamin K epoxide reductase
por: Takeda, Kazuki, et al.
Publicado: (2020)

Effects of Obesity on Warfarin Reversal With Vitamin K
por: Luc, Stanley A., et al.
Publicado: (2019)

VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?
por: Oldenburg, Johannes, et al.
Publicado: (2015)

Mediterranean Diet Decreases the Initiation of Use of Vitamin K Epoxide Reductase Inhibitors and Their Associated Cardiovascular Risk: A Randomized Controlled Trial
por: Castro-Barquero, Sara, et al.
Publicado: (2020)

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
por: Tavares, Letícia C., et al.
Publicado: (2018)

A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase
por: Jin, Da-Yun, et al.
Publicado: (2023)

Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639G<A) gene polymorphisms & their effect on acenocoumarol dose in patients with mechanical heart valve replacement
por: Kaur, Anupriya, et al.
Publicado: (2013)

Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy
por: Khansari, Nakisa, et al.
Publicado: (2022)

Warfarin Dosing Requirement According to Body Mass Index
por: Alshammari, Abdullah, et al.
Publicado: (2020)

Phylogeny of the Vitamin K 2,3-Epoxide Reductase (VKOR) Family and Evolutionary Relationship to the Disulfide Bond Formation Protein B (DsbB) Family
por: Bevans, Carville G., et al.
Publicado: (2015)

The catalytic mechanism of vitamin K epoxide reduction in a cellular environment
por: Shen, Guomin, et al.
Publicado: (2020)

Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European‐Americans and Egyptians
por: Hamadeh, IS, et al.
Publicado: (2016)

Effects of VKORC1 Genetic Polymorphisms on Warfarin Maintenance Dose Requirement in a Chinese Han Population
por: Yan, Xiaojuan, et al.
Publicado: (2015)

Impact of regular physical activity on weekly warfarin dose requirement
por: Rouleau-Mailloux, Étienne, et al.
Publicado: (2015)

Pharmacological effects of a vitamin K(1) 2,3-epoxide reductase (VKOR) inhibitor, 3-acetyl-5-methyltetronic acid, on cisplatin-induced fibrosis in rats
por: UCHIDA, Masashi, et al.
Publicado: (2017)

Warfarin-quetiapine interaction causing hemorrhage
por: Bavle, Amar D., et al.
Publicado: (2016)

The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population
por: Taşkın, Birce Dilge, et al.
Publicado: (2016)

Characterizing variability in warfarin dose requirements in children using modelling and simulation
por: Hamberg, Anna-Karin, et al.
Publicado: (2014)

New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) – The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations()
por: Matagrin, Benjamin, et al.
Publicado: (2013)

Enzyme Polymorphism in Warfarin Dose Management After Pediatric Cardiac Surgery
por: Tabib, Avisa, et al.
Publicado: (2015)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
por: Gallagher, Celine, et al.
Publicado: (2019)

Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?
por: Chao, T, et al.
Publicado: (2023)

Association of GGCX gene polymorphism with warfarin dose in atrial fibrillation population in Xinjiang
por: Kamali, Xiayizha, et al.
Publicado: (2013)

Vitamin K Epoxide Reductase Complex Subunit 1-Like 1 (VKORC1L1) Inhibition Induces a Proliferative and Pro-inflammatory Vascular Smooth Muscle Cell Phenotype
por: Aksoy, Adem, et al.
Publicado: (2021)

Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy
por: Park, Ji Na, et al.
Publicado: (2015)

The Contribution of VKORC1 and CYP2C9 Genetic Polymorphisms and Patients’ Demographic Characteristics with Warfarin Maintenance Doses: A Suggested Warfarin Dosing Algorithm
por: Khaleqsefat, Esmat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6l97jkiedp7ipo3vu6mdqr9umu